- Home
- ZLAB vs TSLX Comparison
ZLAB vs TSLX Comparison
Compare ZLAB & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- TSLX
- Stock Information
- Founded
- ZLAB 2013
- TSLX 2010
- Country
- ZLAB China
- TSLX United States
- Employees
- ZLAB N/A
- TSLX N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- TSLX Investment Managers
- Sector
- ZLAB Health Care
- TSLX Finance
- Exchange
- ZLAB Nasdaq
- TSLX Nasdaq
- Market Cap
- ZLAB 3.6B
- TSLX 2.1B
- IPO Year
- ZLAB 2017
- TSLX 2014
- Fundamental
- Price
- ZLAB $36.40
- TSLX $24.37
- Analyst Decision
- ZLAB Buy
- TSLX Strong Buy
- Analyst Count
- ZLAB 5
- TSLX 8
- Target Price
- ZLAB $54.28
- TSLX $22.69
- AVG Volume (30 Days)
- ZLAB 886.6K
- TSLX 598.4K
- Earning Date
- ZLAB 08-05-2025
- TSLX 07-30-2025
- Dividend Yield
- ZLAB N/A
- TSLX 8.54%
- EPS Growth
- ZLAB N/A
- TSLX N/A
- EPS
- ZLAB N/A
- TSLX 1.89
- Revenue
- ZLAB $418,326,000.00
- TSLX $481,092,000.00
- Revenue This Year
- ZLAB $44.07
- TSLX N/A
- Revenue Next Year
- ZLAB $49.13
- TSLX N/A
- P/E Ratio
- ZLAB N/A
- TSLX $12.90
- Revenue Growth
- ZLAB 43.72
- TSLX 4.73
- 52 Week Low
- ZLAB $16.01
- TSLX $18.58
- 52 Week High
- ZLAB $44.34
- TSLX $24.42
- Technical
- Relative Strength Index (RSI)
- ZLAB 52.67
- TSLX 71.44
- Support Level
- ZLAB $34.79
- TSLX $23.67
- Resistance Level
- ZLAB $36.73
- TSLX $23.98
- Average True Range (ATR)
- ZLAB 1.23
- TSLX 0.39
- MACD
- ZLAB -0.46
- TSLX 0.06
- Stochastic Oscillator
- ZLAB 25.91
- TSLX 97.46
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About TSLX Sixth Street Specialty Lending Inc.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.